期刊文献+

新疆汉族、维吾尔族及哈萨克族食管癌血清蛋白质指纹图谱 被引量:5

Identification of esophageal carcinoma-associated proteins by proteomics in Han,Uygur and Kazakh patients with esophageal carcinoma in Xinjiang,China
下载PDF
导出
摘要 目的:探讨新疆主要民族之间食管癌患者血清蛋白质指纹图谱的差异.方法:用表面增强激光解吸电离飞行时间质谱技术(SELDI-TOF-MS)检测43例汉族、43例维吾尔族及41例哈萨克族食管癌血清蛋白质指纹图谱,所得结果用ZUCI-PDAS软件分析处理,筛选血清差异性蛋白质.结果:同民族间的血清蛋白质指纹图谱存在明显差异.汉族组与维吾尔族组中质荷比为4310.0109,8713.0142,7993.0223的3个蛋白质峰差异具有统计学意义(P<0.05);汉族组与哈萨克族食管癌组中质荷比为4310.0184,8167.9277,8158.1117,13789.4864,8067.7056,4611.9098,7993.4422,16146.8706的8个蛋白质峰差异具有统计学意义(P<0.05);维吾尔族组与哈萨克族组中质荷比分别为9161.7944,4611.6342,6649.6163,4979.3807的4个蛋白质峰差异具有统计学意义(P<0.05);质荷比4310.0109的蛋白峰在汉族组中呈低表达,而在维吾尔族组和哈萨克族组中均呈高表达.在维吾尔族组和哈萨克族组之间该蛋白峰未见到有差异.结论:汉族、维吾尔族及哈萨克族食管癌患者之间血清蛋白质指纹图谱的差异具有统计学意义,在新疆地区建立不同民族食管癌患者血清蛋白质指纹图谱疾病诊断模型有一定的临床意义. AIM:To conduct a serum protein profile analysis in Han,Uygur and Kazakh patients with esophageal carcinoma (EC) in Xinjiang,China.METHODS:Serum samples from patients with EC (43 Han,43 Uygur and 41 Kazakh subjects) were detected by weak cation exchange (CM10) protein chip assay using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) technology to screen differentially expressed serum markers for EC.RESULTS:The peaks at the mass to charge ratios (M/Z) 4 310.0109,8 713.0142 and 7 993.0223 were significantly different between Han and Uygur EC patients (P 0.05).The peaks at M/Z 4 310.0184,8 167.9277,8 158.1117,13 789.4864,8 067.7056,4 611.9098,7 993.4422 and 16 146.8706 were significantly different between Han and Kazakh EC patients (P 0.05).The peaks at M/Z 9 161.7944,4 611.6342,6 649.6163 and 4 979.3807 were significantly different between Uygur and Kazakh EC patients (P 0.05).The peat at M/Z 4 310.0109 was highly expressed in Uygur and Kazakh patients but lowly expressed in Han patients.CONCLUSION:The protein fingerprints are significantly different among Han,Uygur and Kazakh EC patients in Xinjiang,China,which can be used to build a diagnostic model of EC.
出处 《世界华人消化杂志》 CAS 北大核心 2010年第17期1773-1779,共7页 World Chinese Journal of Digestology
基金 新疆维吾尔自治区自然科学基金项目 No.200821147~~
关键词 表面增强激光解吸电离飞行时间质谱 食管癌 汉族 维吾尔族 哈萨克族 蛋白指纹图谱 Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry Esophageal carcinoma Han Kazakh Serum Proteomics
  • 相关文献

参考文献32

  • 1Lam A K.Molecular biology of esophageal squamous cell carcinoma.Crit Rev Oncol Hematol 2000;33:71-90.
  • 2Parkin DM,Bray F,Ferlay J,Pisani P.Estimating the world cancer burden:Globocan 2000.Int J Cancer 2001;94:153-156.
  • 3Pearson FG,Cooper JD,Deslauriers J,Ginsberg RJ,Hiebert CA,Patterson GA,Urschel HC Jr.Esophageal Surgery.2ed Edition.Churchill Livingstone,Elsevicr Science,Kidlington,UK.2002:714.
  • 4林东昕,谭文,陆士新,邢德印.中国食管癌分子流行病学研究[J].中华流行病学杂志,2003,24(10):939-943. 被引量:75
  • 5Smith RD.Probing proteomes--seeing the whole picture? Nat Biotechnol 2000;18:1041-1042.
  • 6Issaq HJ,Conrads TP,Prieto DA,Tirumalai R,Veenstra TD.SELDI-TOF MS for diagnostic proteomics.Anal Chem 2003;75:148A-155A.
  • 7Weinberger SR,Dalmasso EA,Fung ET.Current achievements using ProteinChip Array technology.Curr Opin Chem Biol 2002;6:86-91.
  • 8Anderson NL,Anderson NG.The human plasma proteome:history,character,and diagnostic prospects.Mol Cell Proteomics 2002;1:845-867.
  • 9Bergman AC,Benjamin T,Alaiya A,Waltham M,Sakaguchi K,Franzén B,Linder S,Bergman T,Auer G,Appella E,Wirth PJ,J(o)rnvall H.Identification of gel-separated tumor marker proteins by mass spectrometry.Electrophoresis 2000;21:679-686.
  • 10He QY,Chen J,Kung HF,Yuen AP,Chiu JF.Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics.Proteomics 2004;4:271-278.

二级参考文献81

  • 1郑燕华,邹德威,冯凯,崔彦,张铭,许洋,李宁,张建中.蛋白芯片技术筛选肝癌血清标志蛋白的初步研究[J].中华检验医学杂志,2005,28(6):628-631. 被引量:26
  • 2Plebani M. Proteomics: The next revolution in laboratory medicine? [J]. Clin Chim Acta,2005,357,113-122.
  • 3Anderson N L. The role of multiple proteomic platforms in pipeline for new diagnostic[J]. Mol Cell Proteomics,2005,4(10) : 1441-1444.
  • 4Kasper C E. Genomics and proteomics methodologies for vulnerable populations research [ J ]. Annu Rev Nurs Res,2007,25 : 191-217.
  • 5Jones B A, Liu W L, Araujo A B, et al. Explaining the race difference in prostate cancer stage at diagnosis[ J]. Cancer Epidemiol. Biomarkers Prev,2008,17 (10) :2825-2834.
  • 6Pan Q, Luo x P, Chegini N. Genomic and proteomic profiling I : Leiomyomas in African and American and Caucasians [ J ]. Reprod Biol Endocrinol,2007,5 ( 1 ) :34-48.
  • 7Gelfi C, De P S, Ripamonti M, et al. New aspects of altitude adaptation in Tibetans: a proteomic approach [ J ]. FASEB J,2004,18 ( 3 ) : 612-614.
  • 8Omenn G S, States D J, Adamski M, et al. Overview of the HOPO plasma prote0me project : results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database [ J ]. Proteomics,2005,5 ( 13 ) :3226-3245.
  • 9He P, He H Z, Dai J,et al. The human plasma proteome: Analysis of Chinese serum Using shotgun strategy[ J]. Proteomics,2005,5 (15) : 3442-3453.
  • 10Anderson N L, Polanski M, Pieper R, et al. The human plasma proteome : A nonredundant list developed by combination of four sepatate sources [ J ]. Mol Cell Proteomics ,2004,3 (4) :311-326.

共引文献81

同被引文献75

引证文献5

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部